BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update ...Middle East

PR Newswire - News
BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update
JERUSALEM, June 1, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceuticals company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today published its...

Read More Details
Finally We wish PressBee provided you with enough information of ( BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update )

Also on site :



Latest News